Physician profile
Ming T Lai
NPI 1124023890
$7,510.48
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,028 · 2020: $1,680 · 2021: $1,237 · 2022: $846 · 2023: $381 · 2024: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $3,469.59 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,471.08 | 2019-2024 | Farxiga, Airsupra |
| Novo Nordisk INC | $756.48 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.46 | 2019-2021 | |
| Lilly USA, LLC | $209.14 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $188.28 | 2019 | |
| Glaxosmithkline, LLC. | $161.95 | 2019-2021 | |
| Allergan, INC. | $140.12 | 2020 | |
| Pfizer INC. | $117.89 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $108.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $106.40 | 2019-2022 | |
| Medicure Pharma INC. | $60.25 | 2020 | |
| Esperion Therapeutics, INC. | $50.63 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $49.74 | 2019-2021 | |
| Amgen INC. | $48.79 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $46.63 | 2019 | |
| Amarin Pharma, INC. | $44.03 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $42.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.48 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $19.87 | 2021 | |
| Abbvie INC. | $16.10 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.77 | 2019 | |
| Exact Sciences Corporation | $13.69 | 2024 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.